In vitro diagnosis and anti-LAV/HTLV IIi
Meyer-Lüerssen, D.
Journal of Clinical Chemistry and Clinical Biochemistry 23(12): 889-890
1985
ISSN/ISBN: 0340-076X PMID: 3007653 Document Number: 265754
Document emailed within 1 workday
Related Documents
Mahieux, R.; Gessain, A. 2005: Les nouveaux rétrovirus humains HTLV-3 et HTLV-4 - New human retroviruses : HTLV-3 and HTLV-4 Medecine Tropicale 65(6): 525-528Ikeda, K.; Inaba, N.; Takamizawa, H. 1993: Vertical transmission human T-cell lymphotropic virus type-i (HTLV-I)--genetic diagnosis and assessment of the probable routes of HTLV-i infection Nihon Sanka Fujinka Gakkai Zasshi 45(11): 1283-1288
Dickmeiss, E.; Christiansen, A.H.; Smith, E. 2001: Screening of donor blood for viral markers. Anti-HIV, HBsAg and anti-HTLV-I/II in Denmark 1990-1999 Ugeskrift for Laeger 163(19): 2623-2628
Miwa, M.; Shimotohno, K.; Hoshino, H.; Fujino, M.; Sugimura, T. 1984: Detection of pX proteins in human T-cell leukemia virus (HTLV)-infected cells by using antibody against peptide deduced from sequences of X-IV DNA of HTLV-i and Xc DNA of HTLV-Ii proviruses Gan 75(9): 752-755
Kano, S. 1999: Serological diagnosis of streptococcal infection (anti-streptolysin O; ASO, anti-streptokinase; ASK, anti-deoxyribonuclease B; ADNB, anti-hyaluronidase; AHD, anti-streptococcal polysaccharide; ASP) Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 107-116
Neill, A.G.; Fernandes-Costa, F.J. 1990: Anti-HTLV-i in blood donors in Natal South African Medical Journal 78(6): 376
Neale, T.J.; Dagger, J.; Fong, R.; Humble, M.; Meech, P.; Hatfield, P.J.; Morrison, R.B. 1985: False positive anti-HTLV IIi serology New Zealand Medical Journal 98(789): 914
Jesson, W.J.; Thorp, R.W.; Mortimer, P.P.; Oates, J.K. 1986: Prevalence of anti-HTLV-IIi in UK risk groups 1984/85 Lancet 1(8473): 155
Mitsuya, H.; Matsushita, S.; Harper, M.E.; Broder, S. 1985: Pharmacological inhibition of infectivity of HTLV-IIi in vitro Cancer Research 45(9 Suppl): 4583s-4587s
Sarin, P.S.; Gallo, R.C.; Scheer, D.I.; Crews, F.; Lippa, A.S. 1985: Effects of a novel compound (AL 721) on HTLV-III infectivity in vitro New England Journal of Medicine 313(20): 1289-1290
Muncunill, J.; Forteza, A.; Forner, N.; Forteza-Rei, J. 1986: Systematic detection of anti-LAV/HTLV-IIi antibodies in blood donors and hemophiliacs Medicina Clinica 86(13): 565
Scheiermann, N.; Gesemann, M.; Riffelmann, H.D. 1985: Detection of anti-HTLV-IIi antibodies in gammaglobulin preparations for intramuscular injection Deutsche Medizinische Wochenschrift 110(49): 1912-1913
Cortés, A.; Francisco, C.; Larrañaga, M.J.; Cárdenas, J.M. 1987: Prevalence of anti-HTLV-IIi antibodies in volunteer blood donors in Guipuzcoa Medicina Clinica 88(1): 38-39
Lecour, H.; Santos Ferreira, M.; Lourenço, M.; Pestana, M.; Seara, A.; Cerqueira Magro, F.; Fernandes, S.; Loureiro, A.; Amaral, I.; Rodrigues, A. 1987: Prevalence of anti-LAV/HTLV-IIi in Portuguese drug addicts and hemodialyzed patients Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 6(2 Suppl): 635-636
Lynn, T.C.; Hsieh, R.P.; Lin, K.T.; Shen, M.C.; Chen, D.S.; Wang, C.H.; Liu, C.H.; Wang, J.H.; Lai, M.Y.; Liou, M.F. 1984: Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics: a preliminary report Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 17(3): 172-176
Petricciani, J.C.; McDougal, J.S.; Evatt, B.L. 1985: Case for concluding that heat-treated, licensed anti-haemophilic factor is free from HTLV-IIi Lancet 2(8460): 890-891
Sertöz, R.üçh.; Turhan, A.; Bozkurt, H.; Samlıoğlu, P.ın.; Değirmenci, A.; Aydınok, Y.şi.; Erensoy, S. 2010: Investigation of anti-HTLV I/Ii seroprevalence in healthy blood donors in Izmir region, Turkey Mikrobiyoloji Bulteni 44(4): 579-584
Chieco-Bianchi, L.; Saggioro, D.; Del Mistro, A.; Montaldo, A.; Majone, F.; Levis, A.G. 1988: Chromosome damage induced in cord blood T-lymphocytes infected in vitro by HTLV-i Leukemia 2(12 Suppl): 223s-232s
Chimirri, A.; Grasso, S.; Montforte, A.M.; Monforte, P.; Zappalà, M. 1994: Anti-HIV agents. III. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]imidazo[4,5-b]pyridines Farmaco 49(5): 345-348
Chimirri, A.; Grasso, S.; Monforte, A.M.; Monforte, P.; Rao, A.; Zappalà, M.; Bruno, G.; Nicolò, F.; Scopelliti, R. 1997: Anti-HIV agents. V. Synthesis, structure and in vitro anti-HIV activity of novel 1H,3H-naphtho[2',3':4,5]imidazo[1,2-c]thiazoles Farmaco 52(11): 673-677